- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04177147
Primary Care Clinicians' Responses to a Hypoglycemia Risk Calculator for Diabetes Mellitus in Ambulatory Care (HG_Tool)
November 22, 2019 updated by: Michael Weiner, Indiana University
Hypoglycemia (HG) is common and can be dangerous in diabetes mellitus, so identifying patients at risk may lead to useful preventive strategies and improved quality of care and health outcomes.
This study will test the implementation of a computerized alert tool for clinicians.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Diabetes mellitus is one of the most common non-communicable diseases worldwide and is a major cause of morbidity and mortality.
An estimated 346 million people had diabetes in 2011, and diabetes is predicted to become the seventh leading cause of death in the world by the year 2030.
In the United States, the incidence of diabetes nearly tripled between 1990 and 2010, with 1.9 million new cases diagnosed in 2010.
Hypoglycemia (HG) is recognized as a limiting factor in optimal glycemic management of patients with diabetes.
This potentially costly condition, occurring in approximately 20% to 60% of patients who receive oral medications for diabetes, threatens patient safety, quality of life, and potentially, cardiovascular health.
Investigators have identified risk factors for HG, built a risk calculator for use by clinicians, integrated the calculator into the G3 electronic medical record system, and demonstrated our ability to collect data about outcomes.
In this project, investigators studied the outcomes of implementing the risk calculator tool into clinical practice in ambulatory primary care.
The findings and tools developed from this project will promote improved patient safety and medical care for diabetes.
Study Type
Interventional
Enrollment (Actual)
220
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
The study included clinicians who were scheduled to provide primary care during the four-month intervention period.
Inclusion Criteria for patients:
- Being at least 21 years of age
- Have been prescribed or dispensed a drug for diabetes mellitus
Exclusion Criteria for patients:
N/A
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Clinical decision support via alert tool
Clinicians received access to the electronic alert tool, which automatically displayed patients' risk of hypoglycemia.
|
The alert tool displays the risk of hypoglycemia for outpatients with diabetes mellitus.
|
No Intervention: Usual care
Clinicians did not receive access to the electronic alert tool.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with hypoglycemia during the study period
Time Frame: Five-month follow-up period
|
Participants with hypoglycemia had blood glucose level less than 70 mg/dL
|
Five-month follow-up period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with changes to prescriptions for diabetes or antibiotics: new, refilled, changed, or discontinued
Time Frame: Five-month follow-up period
|
Prescriptions for insulin and sulfonylurea drugs are assessed
|
Five-month follow-up period
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with inpatient or outpatient medical encounters
Time Frame: Five-month follow-up period
|
Includes emergency encounters
|
Five-month follow-up period
|
Number of participants undergoing patient education related to diabetes
Time Frame: Five-month follow-up period
|
Text analysis of medical encounter notes
|
Five-month follow-up period
|
Number of A1c, glucose, and creatinine blood tests
Time Frame: Five-month follow-up period
|
Mean and SD
|
Five-month follow-up period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 14, 2016
Primary Completion (Actual)
September 30, 2016
Study Completion (Actual)
September 30, 2016
Study Registration Dates
First Submitted
November 21, 2019
First Submitted That Met QC Criteria
November 22, 2019
First Posted (Actual)
November 26, 2019
Study Record Updates
Last Update Posted (Actual)
November 26, 2019
Last Update Submitted That Met QC Criteria
November 22, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Merck RI 22
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Clinical decision support via alert tool
-
University of FloridaRecruitingTelemedicine | PediatricsHaiti
-
University of PittsburghAgency for Healthcare Research and Quality (AHRQ)CompletedContraception | Abnormalities, Drug-Induced | TeratogensUnited States
-
Children's Hospital of PhiladelphiaNational Library of Medicine (NLM)CompletedComprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants (PreemieCDS)PrematurityUnited States
-
Northwestern UniversityNot yet recruitingHeart Failure With Reduced Ejection FractionUnited States
-
Seattle Children's HospitalCompleted
-
Oregon Health and Science UniversityEnrolling by invitationAtrial FibrillationUnited States
-
University of Colorado, DenverATI Physical TherapyCompletedTotal Knee ReplacementUnited States
-
Mayo ClinicUniversity of British ColumbiaCompletedSepsis | Shock | Critical Illness | Respiratory Failure | BleedingChina, India, Croatia, Congo, Fiji, Peru
-
Brittany LapinLearning Health Systems Rehabilitation Research NetworkRecruitingPhysical Therapy EvaluationUnited States
-
VA Office of Research and DevelopmentRecruitingTotal Knee ArthroplastyUnited States